- Home
- MASS vs IOBT Comparison
MASS vs IOBT Comparison
Compare MASS & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MASS
- IOBT
- Stock Information
- Founded
- MASS 2012
- IOBT 2014
- Country
- MASS United States
- IOBT Denmark
- Employees
- MASS N/A
- IOBT N/A
- Industry
- MASS Medical/Dental Instruments
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- MASS Health Care
- IOBT Health Care
- Exchange
- MASS Nasdaq
- IOBT Nasdaq
- Market Cap
- MASS 84.3M
- IOBT 91.6M
- IPO Year
- MASS 2020
- IOBT 2021
- Fundamental
- Price
- MASS $6.90
- IOBT $1.41
- Analyst Decision
- MASS Buy
- IOBT Strong Buy
- Analyst Count
- MASS 3
- IOBT 3
- Target Price
- MASS $5.33
- IOBT $9.33
- AVG Volume (30 Days)
- MASS 699.4K
- IOBT 173.0K
- Earning Date
- MASS 08-05-2025
- IOBT 08-12-2025
- Dividend Yield
- MASS N/A
- IOBT N/A
- EPS Growth
- MASS N/A
- IOBT N/A
- EPS
- MASS N/A
- IOBT N/A
- Revenue
- MASS $63,986,000.00
- IOBT N/A
- Revenue This Year
- MASS N/A
- IOBT N/A
- Revenue Next Year
- MASS $22.44
- IOBT N/A
- P/E Ratio
- MASS N/A
- IOBT N/A
- Revenue Growth
- MASS 32.85
- IOBT N/A
- 52 Week Low
- MASS $1.81
- IOBT $0.66
- 52 Week High
- MASS $8.06
- IOBT $1.73
- Technical
- Relative Strength Index (RSI)
- MASS 53.47
- IOBT 55.98
- Support Level
- MASS $6.33
- IOBT $1.37
- Resistance Level
- MASS $7.27
- IOBT $1.48
- Average True Range (ATR)
- MASS 0.44
- IOBT 0.09
- MACD
- MASS -0.05
- IOBT -0.01
- Stochastic Oscillator
- MASS 45.60
- IOBT 68.33
About MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.